FutureStarr

Sann Stock:

Sann Stock:

Sann Stock:

Sann Stock

Sann Stock is a search engine that monitors stock market transactions and lets you buy and sell shares online. The app is available for iOS and Android and employs a clean and simple interface that is straightforward and easy to use. We recently reviewed Sann Stock and provide a detailed and engaging look at the app and its features. StockTwits: It’s no secret that following the market is incredibly addicting, and it gets even more so when you can.

Santhera and Reveragen Announce Positive Topline Results With Vamorolone After Completion of the Vision-Dmd Study

Ad hoc announcement pursuant to Art. 53 LR Vamorolone given throughout the study showed sustained efficacy across multiple endpoints over 48 weeks and the good safety and tolerability profile was confirmedSwitching from prednisone to vamorolone after week 24 maintained efficacy and improved on multiple safety parameters including restoration of growth trajectory and reduction of behavioral changes up to week 48Switching from placebo to vamorolone after week 24 resulted in an improvement of multi (Source: finance.yahoo.com)

finance.yahoo.com)Santhera and Reveragen Announce Successful Fda Pre-Nda Meeting for Vamorolone in DuchenneAd hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, and Rockville, MD, USA, November 17, 2021 –Santhera Pharmaceuticals (SIX: SANN) and ReveraGen Biopharma (US: private) announce the successful completion of a first pre-NDA meeting with the U.S. Food and Drug Administration (FDA) for vamorolone for the treatment of Duchenne muscular dystrophy (DMD). The FDA considered both the proposed clinical efficacy and safety data sufficient for an NDA filing. Based on the Fast Track Designati (Source: Muscular Dystrophy

Santhera Appoints Stephanie Brown As President North America and Member of the Executive Management Team

Ad hoc announcement pursuant to Art. 53 LR Pratteln, Switzerland, November 4, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces the appointment of Stephanie Brown as President North America and a member of Santhera’s Executive Management team, effective December 1, 2021. Stephanie Brown joins Santhera with an extensive background leading commercial businesses and global franchises in North America and Europe. Most recently, she was Senior Vice President and Head of the Rare Diseases Franchis (Source: finance.yahoo.com)

 

Related Articles